文献速递肝病

IL-2通过损害晚期肝硬化患者滤泡辅助性T细胞导致肝硬化相关免疫功能障碍

IL-2 contributes to cirrhosis-associated immune dysfunction by impairing follicular T helper cells in advanced cirrhosis.
PubMed 文献 · J Hepatol · 2020-10-24

该研究在代偿期(n=37)和失代偿期肝硬化患者(n=82)及无肝硬化对照(n=45)中分析Tfh、Treg、B细胞、循环细胞因子和免疫球蛋白,并在8例失代偿患者中分析肝内T细胞。发现失代偿期患者Tfh细胞频率降低且IL-2信号增强,体外IL-2暴露削弱Tfh表型和辅助功能,Tfh细胞在肝硬化肝脏中几乎检测不到。IL-2信号特征与免疫球蛋白水平相关,而高丙种球蛋白血症预测完整的Tfh细胞库并与良好预后相关。

要点

  • 失代偿期肝硬化患者Tfh细胞频率降低且IL-2信号增强。
  • 体外IL-2暴露削弱Tfh表型和辅助B细胞功能。
  • 高丙种球蛋白血症预测完整Tfh细胞库并与良好生存相关。

核心结论

  • Tfh细胞损伤是肝硬化相关免疫功能障碍中被低估的特征,由IL-2驱动。
  • 失代偿期患者出现高丙种球蛋白血症预测完整的Tfh细胞库并与良好预后相关。

研究设计与样本

  • 研究纳入代偿期肝硬化患者37例、失代偿期肝硬化患者82例和无肝硬化对照45例,分析Tfh、Treg、B细胞、循环细胞因子和免疫球蛋白。
  • 在8例失代偿患者中分析肝内T细胞。
  • 体外评估IL-2对Tfh细胞功能的影响,包括Tfh细胞克隆和T细胞-B细胞共培养(使用克隆和原代扁桃体来源Tfh细胞)。

主要发现

  • 失代偿期肝硬化患者Tfh细胞频率降低,表型特征提示IL-2信号增强。
  • 这些患者可溶性IL-2受体(sCD25)升高,CD4 T细胞对IL-2信号反应性增强(以STAT5磷酸化为特征)。
  • 体外IL-2暴露削弱Tfh表型,并在与初始B细胞共培养实验中导致Tfh辅助功能受损。
  • 肝硬化肝脏中Tfh细胞几乎检测不到。
  • 失代偿患者Tfh细胞上的IL-2特征与免疫球蛋白水平相关,而免疫球蛋白水平与改善的生存相关。

临床怎么用

  • 在晚期肝硬化患者中,高丙种球蛋白血症可能提示Tfh细胞库相对完整,与较好预后相关。
  • IL-2信号增强可能是晚期肝硬化Tfh细胞损伤的机制,需进一步研究是否可干预。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Patients with decompensated cirrhosis suffer from recurrent infections and inadequate responses to prophylactic vaccinations. However, many patients present with hypergammaglobulinemia (HGG), indicating a sustained ability to generate antibody responses. As follicular T helper (Tfh) cells are central facilitators of humoral immunity, we hypothesized that Tfh cell responses may be altered in advanced liver disease and we aimed to identify the mechanisms underlying any such alterations. METHODS: Tfh, regulatory T (Treg) cells, B cells, circulating cytokines and immunoglobulins were analyzed in cohorts of patients with compensated (n = 37) and decompensated cirrhosis (n = 82) and in non-cirrhotic controls (n = 45). Intrahepatic T cells were analyzed in 8 decompensated patients. The influence of IL-2 on Tfh cell function was evaluated in vitro, including Tfh cell cloning and T cell-B cell co-cultures with clones and primary tonsil-derived Tfh cells. RESULTS: Tfh cell frequencies were reduced in patients with decompensated cirrhosis, with phenotypic signatures indicative of increased IL-2 signaling. Soluble IL-2 receptor (sCD25) was elevated in these patients and CD4 T cells were more responsive to IL-2 signaling, as characterized by STAT5 phosphorylation. IL-2 exposure in vitro diminished the Tfh phenotype and resulted in impaired Tfh helper function in co-culture experiments with naïve B cells. Tfh cells were barely detectable in cirrhotic livers. IL-2 signatures on Tfh cells in decompensated patients correlated with immunoglobulin levels, which were found to be associated with improved survival. CONCLUSIONS: Tfh cell impairment represents a previously underestimated feature of cirrhosis-associated immune dysfunction that is driven by IL-2. The presence of HGG in decompensated patients predicts an intact Tfh cell compartment and is associated with a favorable outcome. LAY SUMMARY: Patients with advanced cirrhosis often fail to generate protective immunity after prophylactic vaccinations and suffer from recurring infections that are associated with high mortality. Follicular T helper (Tfh) cells are specialized CD4 T cells that enable the emergence of antibody responses against microbial pathogens. This report demonstrates that Tfh cells are impaired in patients with advanced cirrhosis due to interleukin-2 signaling, a cytokine that is known to impair the generation of Tfh cells.

来源:J Hepatol,查看原文。版权归原作者所有。

引用

  1. Basho K, Zoldan K, Schultheiss M, et al. IL-2 contributes to cirrhosis-associated immune dysfunction by impairing follicular T helper cells in advanced cirrhosis. J Hepatol. 2020. PMID: 33211012. doi:10.1016/j.jhep.2020.10.012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。